To investigate whether sirtuin 1 (Sirt1) could affect the transcriptional expression of the adipose triglyceride lipase (ATGL) gene, we treated porcine adipocytes with the general Sirt1 activator resveratrol (RES) with the Sirt1 inhibitor nicotinamide (NAM) or a knockdown of Sirt1 by Sirt1-specifi c small interfering RNA (siRNA). The RES (50 μM) activated Sirt1 gene expression and increased ATGL gene expression and glycerol release (P < 0.01). The Sirt1 inhibitor NAM or knockdown with Sirt1 siRNA further proved that the ATGL mRNA abundances were decreased (P < 0.05) after inhibition with Sirt1 in adipocytes. Furthermore, we found the opposite Sirt1 regulation pattern for PPARγ to that of ATGL in adipocytes. In summary, Sirt1 regulates the transcriptional expression of ATGL in adipocytes, and PPARγ appears to have an important role in this process. These results add to our understanding of the role of Sirt1 in adipose mobilization.
INTRODUCTION
Adipose triglyceride lipase (ATGL) is a major enzyme in triacylglycerol catabolism (Jenkins et al., 2004; Schweiger et al., 2006; Lass et al., 2011) , which promotes the catabolism of stored fat in adipose and nonadipose tissues (Zimmermann et al., 2004; Lass et al., 2006; Smirnova et al., 2006) . The data accumulated thus far indicate that ATGL is downregulated in obesity and may contribute to obesity-associated metabolic disorders (Schoenborn et al., 2006; Turpin et al., 2011) . Although ATGL has been cloned in many animals and its regulation by hormones has been studied (Villena et al., 2004; Kralisch et al., 2005; Kershaw et al., 2006) , information is limited regarding the underlying mechanisms that regulate ATGL gene expression in animals.
Sirtuin 1 (Sirt1), a nicotinamide adenine dinucleotide-dependent histone deacetylase, is related to cell proliferation and differentiation (Langley et al., 2002) , apoptosis (Motta et al., 2004; Kitamura et al., 2005) , and metabolism (Rodgers et al., 2005) . Recent studies indicate that Sirt1 not only is an important longevity factor but may also play a key modulatory role in animal fat metabolism and muscle development (Picard and Guarente, 2005; Lomb et al., 2010; Xu et al., 2010) . Sirtuin 1 regulates lipid metabolism and decreases adipocyte size by repressing PPARγ (Picard et al., 2004) . However, the mechanism underlying the regulation of lipolysis by Sirt1 is poorly understood. Furthermore, whether Sirt1 is involved in regulating gene expression of the lipolytic enzyme is unclear.
Therefore, the current study was conducted to examine whether Sirt1 could affect ATGL expression in adipocytes by treating porcine adipocytes with the Sirt1 activator, Sirt1 inhibitor, or knockdown of Sirt1. The expression of PPARγ was also studied. This work has the potential to increase our understanding of the role of Sirt1 and ATGL in lipid metabolism and fat disposition in animals.
MATERIAL AND METHODS
All procedures were approved by the University of Zhejiang Institutional Animal Care and Use Committee.
Animals and Cell Culture
Subcutaneous adipose tissue was collected from piglets (from 5 to 7 d of age), and porcine preadipocytes were prepared by methods previously described (Shan et al., 2008 (Shan et al., , 2009b . The cells from each pig were isolated and used separately. The cells were washed [Dulbecco's Modifi ed Eagle Medium/HamF12 (DMEM/F12); Gibco Laboratories, Grand Island, NY)], stained with Rapaport's stain, and counted on a hemocytometer. The porcine preadipocytes were seeded on 6-well (35-mm) tissue culture plates (Shanghai Sangon Co., Ltd, Shanghai, China) at a density of 2 × 10 4 cells/ cm 2 in complete medium [DMEM/F12 + 10% fetal bovine serum (FBS) + 100 units (U) penicillin + 100 U streptomycin]. Cells were cultured at 37°C under a humidifi ed atmosphere of 95% air and 5% CO 2 . Media were changed every 3 d. After confl uence, the cells were cultured in the complete media for 10 d for lipid fi ling. Cells were treated with Sirt1 activator resveratrol (RES) or the inhibitor nicotinamide (NAM) after 10 d of lipid fi lling. For RES treatments, porcine adipocytes were incubated with either 25 or 50 μM RES for 48 h for a dose-response experiment, and 50 μM of RES in DMEM/F12 (without FBS and phenol red) for 24 and 48 h for time-response experiments. For NAM treatments, porcine adipocytes were incubated with either 100 or 150 μM NAM for 48 h. Gene expression was determined by real-time quantitative PCR. Glycerol release was employed as an index of lipolysis and was determined using the glycerol kit (Applygen Technologies Inc., Beijing, China).
RNA Interference
On the basis of our previous studies (Shan et al., 2009a (Shan et al., , 2010 , the effective target sequence of porcine Sirt1-specifi c small interfering RNA (siRNA) for RNA interference (RNAi) was used for knockdown of Sirt1. Cells were plated in 2 mL of DMEM/F12 medium (with FBS and without antibiotics) 1 d before transfection to yield 90% confl uence at the time of transfection. Transfections were performed on d 2 (Lipofectamine 2000; Invitrogen Life Technologies, Carlsbad, CA) according to the manufacturer's protocol. The control group was transfected with the empty plasmid. For RES + Sirt1 siRNA treatments, cells were treated with 50 μM RES in conjunction with transfection with Sirt1 siRNA. Gene expression was determined 48 h after transfection.
Total RNA Extraction and Reverse Transcription
Total RNA was isolated from the collected cells (Trizol Reagent; Invitrogen Life Technologies) according to the manufacturer's instructions. All RNA was treated with RNase-free DNase l (Takara Biotechnology Co., Ltd., Dalian, China) to remove contaminating genomic DNA. The purity and concentration of total RNA were measured by a spectrophotometer at 260 and 280 nm, respectively. Ratios of absorption (260/280 nm) of all samples were between 1.8 and 2.0. A total of 2 μg of RNA were used for reverse transcription, as published previously (Shan et al., 2008) .
Quantitative Real-Time PCR
The quantitative real-time PCR was conducted (Applied Biosystems 7500 Fast Real-Time PCR System; Applied Biosystems, Foster City, CA) with a kit (SYBR Premix Ex Taq Kit; Takara Biotechnology Co., Ltd.) and gene-specifi c primers; 18S rRNA was used as the reference gene. The oligonucleotide primers used for the real-time PCR were designed to span genomic introns. The 2 -∆∆CT method was used to analyze the relative changes in the expression of each gene (Shan et al., 2009b) . The measurements were repeated 3 times.
Immunofl uorescence and Confocal Microscopy
Immunofl uorescence assays were performed as previously described . Briefl y, cells were fi xed in methanol at −20°C for 10 min, washed 3 times in 0.01 M PBS [pH 7.4, with Tween20 (Santa Cruz Biotechnology, Santa Cruz, CA)] for 5 min each time, and then incubated with rabbit polyclonal antibodies against Sirt1 or PPARγ for 90 min at 37°C (dilution 1:100; Santa Cruz Biotechnology). After washing with PBS, the slides were incubated with the secondary antibodies, washed, and examined with a microscope (Leica TCS SP2 Confocal Microscope; Leica, Mannheim, Germany).
Statistical Analysis
All experimental data are presented as means ± SEM. Comparisons were made by unpaired 2-tailed Student's t tests or 1-way ANOVA, as appropriate. Effects were considered signifi cant at P < 0.05.
RESULTS

Sirtuin 1 RES Upregulation of ATGL Gene Expression and Lipolysis
The effects of the Sirt1 activator RES on lipolysis and expression of the Sirt1 and ATGL genes are presented in Fig. 1 . Exposure of cultured adipocytes to 50 μM RES increased the mRNA abundance of Sirt1 (P = 0.005, Fig. 1B ) and ATGL (P = 0.001, Fig. 1C ). After treatment with 50 μM RES for 24 or 48 h, the mRNA abundances of Sirt1 (Fig. 1E) and ATGL (Fig. 1F ) were increased (P < 0.01) compared with those at 0 h. In addition, the expression of Sirt1 and ATGL was associated with an increase in RES-stimulated glycerol release.
Sirtuin 1 Inhibitor NAM Downregulation of ATGL Gene Expression and Lipolysis
Treatment with 100 or 150 μM NAM decreased glycerol release (P < 0.05; Fig. 2A) . Compared with the control, 100 and 150 μM NAM decreased the Sirt1 mRNA abundance by 36.10% (P = 0.002) and 28.58% (P = 0.006; Fig. 2B ), respectively. Treatment with 100 and 150 μM NAM also decreased the mRNA abundances of ATGL by 24.65% (P = 0.001) and 14.49% (P = 0.007; Fig. 2C ).
siRNA-mediated Knockdown of Sirt1 and ATGL Gene Expression
The results of immunofl uorescence assays showed that Sirt1 protein is not only enriched in the nucleus but also localized in the cytoplasm (Fig. 3A) . After knockdown of Sirt1, the Sirt1 protein abundance appears to be decreased. Furthermore, Sirt1-specifi c siRNA treatment also decreased glycerol release compared with the control (P = 0.009; Fig. 3B ). Compared with the control, treatment of the porcine adipocytes with Sirt1-specifi c siRNA for 48 h resulted in knockdown of porcine Sirt1 mRNA by 53.63% (P = 0.002; Fig. 3C ). The mRNA abundance of porcine ATGL was reduced by 29.54% (P = 0.008; Fig. 3D ).
The Sirt1 RES treatment upregulated (P < 0.01) Sirt1 and ATGL gene expression, whereas Sirt1 siRNA treatment decreased gene expression of Sirt1 (P = 0.024; Fig. 3E ) and ATGL (P = 0.001; Fig. 3F ) compared with the control group. Compared with Sirt1 siRNA treatment, RES + Sirt1 siRNA treatment increased the gene expression of Sirt1 by 56.31% (P = 0.011; Fig. 3E ) and ATGL by 64.51% (P = 0.004; Fig. 3F ).
PPARγ Expression and the Regulation of ATGL
The Sirt1 agonist RES (50 μM) suppressed (P < 0.01) PPARγ mRNA expression (Figs. 4A and 4B) . Conversely, treating cells with the Sirt1-specifi c siRNA or the Sirt1 natural inhibitor NAM increased (P < 0.01) the expression Figure 1 . Effect of the sirtuin 1 (Sirt1) agonist resveratrol (RES) on (A, D) glycerol release, (B, E) expression of Sirt1, and (C, F) expression of adipose triglyceride lipase (ATGL) genes in porcine adipocytes. Glycerol release was normalized to total cellular protein and expressed relative to the control group. Gene expression was determined by real-time quantitative PCR and was normalized to 18S ribosomal RNA and expressed relative to gene expression in the control group. Each column represents the means ± SEM from 3 replicates. **P < 0.01. of PPARγ mRNA (Figs. 4C and 4D ). Immunofl uorescence assay results showed that PPARγ protein was present in nuclei. After knockdown of Sirt1, the expression of PPARγ protein appears to be increased (Fig. 4E) .
DISCUSSION
This study investigated regulation by Sirt1 of ATGL gene expression and lipolysis in adipocytes. The Sirt1 was activated by the agonist RES, inhibited by the inhibitor NAM, and knocked down by Sirt1 siRNA. The mRNA abundance of ATGL increased or decreased after incubation of porcine adipocytes with Sirt1 activator RES or the inhibitor NAM. Similarly, ATGL gene expression was reduced in Sirt1 siRNA transduced cells. In addition, the changes of Sirt1 and ATGL gene expression were associated with glycerol release. Conversely, PPARγ expression was decreased by RES and increased by NAM or Sirt1-specifi c siRNA. Together, these results demonstrated that Sirt1 could upregulate ATGL gene expression in porcine adipocytes, indicating that upregulation of expression of the lipase ATGL is part of the mechanism of Sirt1 action on fat lipolysis. In addition, PPARγ appears to play an important role in this process.
Adipose triglyceride lipase was recently identifi ed and described as an important triglyceride (TG) hydrolase, promoting the catabolism of stored fat in adipose and nonadipose tissues. It catalyzes the initial step in TG hydrolysis in mammalian cells (Kershaw et al., 2006; Smirnova et al., 2006) . However, few data are available concerning the regulation mechanism of ATGL in animals. Sirtuin 1 is a NAD-dependent protein deacetylase that is involved in adipogenesis and may promote fat mobilization in white adipocytes (Picard et al., 2004; Picard and Guarente, 2005; Haemmerle et al., 2006) . To investigate whether Sirt1 could affect ATGL gene expression in adipocytes, we fi rst treated porcine adipocytes with the general Sirt1 activator RES. Consistent with our previous study (Shan et al., 2008) , we observed that RES upregulated the expression of the ATGL gene.
Resveratrol, an activator of Sirt1 (Picard et al., 2004; Backesjo et al., 2006) , has various pharmacological effects, including protecting cells from lipid accumulation, chemoprevention, immunomodulation, antiproliferation, and promoting differentiation (Pervaiz, 2003) . In addition, RES infl uences cell proliferation and stimulates lipolysis. In vitro studies showed that RES reduces TG content and stimulates FFA release in mice 3T3-L1 adipocytes (Picard et al., 2004) . Animal research has shown that RES reduces blood fat and inhibits adipocyte differentiation and fat accumulation by activation of Sirt1 (Picard et al., 2004; Kim et al., 2008) . Resveratrol increases Sirt1 activity through an allosteric interaction, resulting in an increase of Sirt1 affi nity for both nicotinamide adenine dinucleotide and the acetylated substrate (Howitz et al., 2003) . Resveratrol-activated Sirt1 decreases fat accumulation in differentiated adipocytes (Picard et al., 2004) . These results indicated that Sirt1 might regulate the expression of ATGL and therefore lipid mobilization in porcine adipocytes.
Nicotinamide is a strong noncompetitive inhibitor of Sirt1 and has recently been shown to inhibit Sirt1 activity both in vivo and in vitro (Bitterman et al., 2002; Jackson et al., 2003) . It inhibits Sirt1 by inhibiting the activity of the active regulator of Sirt1, which directly regulates Sirt1 functions (Kim et al., 2007) . Nicotinamide decreased the expression of Sirt1 mRNA and greatly stimulated the proliferation and differentiation of porcine preadipocytes (Bai et al., 2008 ). In the current study, the effect of the Sirt1 inhibitor (NAM) on the expression of Sirt1 and ATGL genes was studied to further prove the effect of Sirt1 on the transcription expression of ATGL in porcine adipocytes. We found that NAM inhibited Sirt1 gene expression and, meanwhile, downregulated the expression of ATGL mRNA and decreased glycerol release. This study confi rmed the well-established actions of NAM on Sirt1 (Bitterman et al., 2002; Jackson et al., 2003) , and our fi ndings also indicate that Sirt1 may regulate the expression of ATGL and lipolysis in porcine adipocytes.
The RNAi experiments of the Sirt1 gene provided further support for the regulation role of Sirt1 on the expression of ATGL. Knockdown of Sirt1 with Sirt1-specifi c siRNA resulted in a decrease of Sirt1 and ATGL mRNA and reduced glycerol release. Furthermore, the protein abundances of Sirt1 and ATGL were decreased. It is well known that RNAi is an important biological strategy for gene silencing in multiple organisms (Xia et al., 2002) . These results further demonstrated that Sirt1 could positively regulate the expression of ATGL. This regulation was further demonstrated when siRNA against Sirt1 was used in conjunction with RES. Taken together, these fi ndings indicate that Sirt1 promotes fat mobilization partly through the positive regulation of the key TG hydrolase ATGL. However, more specifi c studies evaluating the precise mode of Sirt1 action on the ATGL gene expression are needed.
Peroxisome proliferator-activated receptor γ is an important insulin-responsive mediator in white adipose tissue (WAT), which stimulates fat synthesis and WAT differentiation. Peroxisome proliferatoractivated receptor γ stimulates lipolysis by regulating the lipolytic potential, including the expression levels of the genes encoding ATGL. Evidence showed that ATGL is subject to transcriptional control by PPARγ-mediated signals . The expression of PPARγ was increased during adipogenisis and showed a direct relationship with ATGL in pigs (Deiuliis et al., 2008) . Sirtuin 1 interacts with PPARγ and represses its transcriptional activity (Picard et al., 2004) . To verify the role of PPARγ in the regulation of ATGL by Sirt1, we also studied the effects of a Sirt1 agonist, a Sirt1 inhibitor, and Sirt1-specifi c siRNA on the gene expression of PPARγ in porcine adipocytes. We found that treated with the Sirt1 agonist, RES decreased expression of the PPARγ gene. Conversely, treating adipocytes with the Sirt1 inhibitor NAM or knockdown of Sirt1 with Sirt1 siRNA increased PPARγ mRNA abundance. Combining the results of the current study and previous documentation, we conclude that the regulation of Sirt1 on ATGL may act partly through PPARγ-mediated signals. However, more specifi c studies evaluating the precise mode of Sirt1 action on the ATGL gene expression are needed.
In conclusion, these results indicated that Sirt1 can upregulate the gene expression of ATGL in porcine adipocytes, and PPARγ appears to play an important role in this process. However, more in-depth studies are required to further characterize the role of Sirt1 in fat metabolism and clarify the regulation mechanism of ATGL in fat depositions in animals.
